BioCardia (BCDA) Other Working Capital Changes (2018)
BioCardia's (BCDA) quarterly Other Working Capital Changes came in at -$30000.0 in Q2 2018, up 14.29% quarter-over-quarter from -$35000.0 in Q1 2018.
Analysis
BioCardia (BCDA) Other Working Capital Changes (2018) Analysis & Trends
BioCardia (BCDA) has reported Other Working Capital Changes for 1 consecutive years, with -$30000.0 the latest figure, recorded in Q2 2018.
- On a quarterly basis, Other Working Capital Changes fell 3.23% year-over-year to -$128000.0 in Q2 2026; TTM through Jun 2026 was -$507000.0, a 8.65% increase from a year earlier, with the FY2025 full-year figure at -$500000.0, down 3.52% from the prior year.
- Other Working Capital Changes was -$128000.0 for Q2 2026 at BioCardia, roughly flat from -$128000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $378000.0 in Q3 2022 and troughed at -$948000.0 in Q2 2022.
- A 5-year average of -$122705.9 and a median of -$93000.0 in 2024 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 171.19% in 2022, down 500.0% in 2022.
- Over 5 years, Other Working Capital Changes stood at -$37000.0 in 2022, then sank by 632.43% to -$271000.0 in 2023, then grew by 21.4% to -$213000.0 in 2024, then gained by 12.21% to -$187000.0 in 2025, then surged by 31.55% to -$128000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$128000.0 (Q2 2026), -$128000.0 (Q1 2026), and -$187000.0 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.60 Bn | 9.76 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.39 Bn | 5.39 Bn | - |
| 3 | Iovance Biotherapeutics | 3.98 Bn | 3.68 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.97 Bn | 3.00 Bn | 251.50 Mn |
| 5 | uniQure | 3.09 Bn | 3.09 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 3.06 Bn | 3.06 Bn | - |
| 7 | Precigen | 2.54 Bn | 2.54 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.38 Bn | 1.58 Bn | 251.87 Mn |
| 9 | Vericel | 2.06 Bn | 1.89 Bn | 56.40 Mn |
| 10 | BioCardia | 13.06 Mn | 8.94 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2018 | -30,000.00 |
| Jun 30, 2018 | -30,000.00 |
| Mar 31, 2018 | -35,000.00 |
| Mar 31, 2018 | -35,000.00 |